Stocktoria
LEMAITRE VASCULAR INC LMAT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-10-19
LEMAITRE VASCULAR INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% |
| Operating margin | 27.2% | 23.8% | 19.0% | 16.6% | 23.6% |
| Net margin | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% |
| Return on assets | 9.4% | 8.0% | 8.7% | 6.6% | 9.2% |
| Return on equity | 14.7% | 13.1% | 10.1% | 7.7% | 10.6% |
| Current ratio | 12.89 | 13.14 | 6.51 | 6.39 | 6.41 |
| Revenue growth | 13.5% | 13.6% | 19.7% | 4.7% | 19.4% |
Source: SEC EDGAR filings · CIK 0001158895 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.